Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05969821
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:10.179950+00:00
Published At
2026-03-23T00:00:00+00:00
Record Updated At
2026-03-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Immune System Diseases", "Autoimmune Diseases", "Inflammation", "Autoinflammatory Diseases", "Vexas Syndrome", "Hematopoiesis Clonal", "Clonal Hematopoiesis of Indeterminate Potential", "Hematologic Diseases", "Myelodysplastic-Myeloproliferative Diseases", "Leukemia Myelomonocytic Chronic", "Myelodysplastic Syndromes", "Myeloproliferative Disorders", "Lymphoproliferative Disorders", "Lymphoma", "Leukemia", "Monoclonal Gammopathy of Undetermined Significance"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-23"
protocolSection.identificationModule.nctId
"NCT05969821"
protocolSection.identificationModule.officialTitle
"Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Immune System Diseases (protocolSection.conditionsModule.conditions)
  • Autoimmune Diseases (protocolSection.conditionsModule.conditions)
  • Inflammation (protocolSection.conditionsModule.conditions)
  • Autoinflammatory Diseases (protocolSection.conditionsModule.conditions)
  • Vexas Syndrome (protocolSection.conditionsModule.conditions)
  • Hematopoiesis Clonal (protocolSection.conditionsModule.conditions)
  • Clonal Hematopoiesis of Indeterminate Potential (protocolSection.conditionsModule.conditions)
  • Hematologic Diseases (protocolSection.conditionsModule.conditions)
  • Myelodysplastic-Myeloproliferative Diseases (protocolSection.conditionsModule.conditions)
  • Leukemia Myelomonocytic Chronic (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Myeloproliferative Disorders (protocolSection.conditionsModule.conditions)
  • Lymphoproliferative Disorders (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Leukemia (protocolSection.conditionsModule.conditions)
  • Monoclonal Gammopathy of Undetermined Significance (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.